"Pharmacy"

During the past decade, Rockwood Clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 32 clinical trials were completed, i.e. on average, 1066.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 13 clinical trials were completed. i.e. 650% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rockwood Clinic" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "AstraZeneca" with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Shire" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rockwood Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Rockwood Clinic" are "Breast Cancer" (6 trials), "Clear Cell Renal Cell Carcinoma" (3 trials), "Diabetes Mellitus, Type 2" (3 trials), "Type 2 Diabetes Mellitus" (3 trials) and "Adenocarcinoma of the Gastroesophageal Junction" (2 trials). Many other conditions were trialed in "Rockwood Clinic" in a lesser frequency.

Most popular intervention types in "Rockwood Clinic" are "Drug" (51 trials), "Other" (24 trials), "Biological" (15 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (16 trials), "Placebo" (10 trials), "Bevacizumab" (7 trials), "Quality-of-Life Assessment" (5 trials) and "AC2993" (4 trials). Other intervention names were less common.

The vast majority of trials in "Rockwood Clinic" are 48 trials for "All" genders, 12 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Rockwood Clinic". undefined are not yet recruiting, 1 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Rockwood Clinic, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Rockwood Clinic, 4 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".